Litcius/Paper detail

<i>In Vitro</i> Susceptibility of Gram-Negative Pathogens to Cefiderocol in Five Consecutive Annual Multinational SIDERO-WT Surveillance Studies, 2014 to 2019

James A. Karlowsky, Meredith A. Hackel, Miki Takemura, Yoshinori Yamano, Roger Echols, Daniel F. Sahm

2021Antimicrobial Agents and Chemotherapy97 citationsDOIOpen Access PDF

Abstract

We report in vitro susceptibility data from five consecutive annual SIDERO-WT surveillance studies (2014 to 2019) for cefiderocol and comparators tested against Gram-negative clinical isolates from North America and Europe. CLSI broth microdilution was used to determine MICs for Enterobacterales ( n = 31,896), Pseudomonas aeruginosa ( n = 7,700), Acinetobacter baumannii complex ( n = 5,225), Stenotrophomonas maltophilia ( n = 2,030), and Burkholderia cepacia complex ( n = 425).

Topics & Concepts

Stenotrophomonas maltophiliaAcinetobacter baumanniiPseudomonas aeruginosaBiologyBurkholderiaMicrobiologyBurkholderia cepacia complexBroth microdilutionAcinetobacterStenotrophomonasCephalosporinOutbreakInfections and bacterial resistanceAntibiotic Resistance in BacteriaNosocomial Infections in ICU
<i>In Vitro</i> Susceptibility of Gram-Negative Pathogens to Cefiderocol in Five Consecutive Annual Multinational SIDERO-WT Surveillance Studies, 2014 to 2019 | Litcius